Francois Nader, Director at Talaris Therapeutics, Inc. (TALS), bought 525,432 shares at $3.52 ($500K) on 2022-07-19, disclosed to the SEC on 2022-09-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.52 | 50,000 | $176K | 35.2% |
| 2 | $3.62 | 52,000 | $188K | 37.6% |
| 3 | $0.00 | 248,432 | $0 | 0.0% |
| 4 | $3.72 | 36,500 | $136K | 27.2% |
| 5 | $0.00 | 138,500 | $0 | 0.0% |
| Total | $0.95 avg | 525,432 |
| $500K |
| 100% |
| Filing → |
| NPSP | SELL | 2013-04-10 | $5.1M | — | Filing → |
| NPSP | BUY | 2011-11-10 | $161K | — | Filing → |
| NPSP | SELL | 2010-04-02 | $65K | — | Filing → |